Effect of Argatroban Plus Intravenous Alteplase vs Intravenous Alteplase Alone on Neurologic Function in Patients With Acute Ischemic Stroke: The ARAIS Randomized Clinical Trial | Cerebrovascular Disease | JAMA

This randomized clinical trial examines the efficacy of argatroban plus altepase for acute ischemic stroke within 4.5 hours from onset.

Related Keywords

China ,Japan ,Shenhe ,Sichuan ,Wenhua ,Tianjin ,Long Wang ,Anhui ,Shenyang ,Liaoning ,Beijing ,Nanjing ,Jiangsu ,Chinese ,Hui Sheng Chen ,National Institutes Of Health Stroke Scale ,National Natural Science Foundation Of China ,Department Of Neurology ,Group Information ,Zhinan Medical Technology Co ,Technology Project Plan Of Liao Ning Province ,Outstanding Young Scientist Program ,Tianjin Institute Of Pharmaceutical Research Co ,Service Pharmaceutical Technology Co ,Boehringer Ingelheim Co ,National Key Rd Program Of China ,Rankin Scale ,National Institutes ,Health Stroke Scale ,General Hospital ,Northern Theatre Command ,Tianjin Institute ,Size Calculation ,Acute Stroke ,Multi Arm Optimization ,Stroke Thrombolysis ,Shenhe District ,Yi Long Wang ,Beijing Tiantan Hospital ,Interest Disclosures ,National Natural Science Foundation ,Beijing Outstanding Young Scientist Program ,National Key Rd Program ,Technology Project Plan ,Liao Ning Province ,